References
- Yurdakul S, Yazici H, Tuzun Y, Pazarli H, Yalcin B, Altac M, et al. The arthritis of Behget's disease: a prospective study. Ann Rheum Dis 1983;42:505–15.
- Pipitone N, Boiardi L, Olivieri I, Cantini F, Salvi F, Malatesta R, et al. Clinical manifestations of Behget's disease in 137 Italian patients: results of a multicenter study. Clin Exp Ftheumatol 2004;22(6 Suppl 36):S46–51.
- Warner JJ, Philip JH, Brodsky GL, Thornhill TS. Studies of nontraumatic osteonecrosis. Manometric and histologic studies of the femoral head after chronic steroid treatment: an experimental study in rabbits. Clin Orthop Relat Res 1987;225:128–40.
- Jones JP Jr. Fat embolism and osteonecrosis. Orthop Clin North Am 1985;16:595–633.
- Matsuo K, Hirohata T, Sugioka Y, Ikeda M, Fukuda A. Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res 1988;234:115–23.
- Shupak R, Bernier V, Rabinovich S, Gordon DA, Wright T. Avas-cular necrosis of bone with rheumatoid vasculitis. J Ftheumatol 1983;10:261–6.
- Wang TY, Avlonitis EG, Relkin R. Systemic necrotizing vasculitis causing bone necrosis. Am J Med 1988;84:1085–6.
- Gusis SE, Milozzi P, Maldonado Cocco JA. Osteonecrosis in Churg-Strauss allergic vasculitis. Clin Ftheumatol 1996;15:622–3.
- Vasoo S, Sangle S, Zain M, D'Cruz D, Hughes G. Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome. Lupus 2005;14:339–45.
- Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, Kelekis DA, Moutsopoulos HM. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthritis Rheum 2003;48:732–6.
- Seleznick MJ, Silveira LH, Espinoza LR. Avascular necrosis asso-ciated with anticardiolipin antibodies. J Ftheumatol 1991;18:1416–7.
- Duzgun N, Ates A. Erosive arthritis in a patient with Behget's disease. Ftheumatol Int 2003;23:265–7.
- Momohara S, Kuwahara M, Kawamura K, Mizumura T, Morimoto R, Tomatsu T. Behget's disease with severe destructive arthritis. Mod Ftheumatol 2001;11:353–5.
- Ftibbens C, Martin y Porras M, Franchimont N, Kaiser MJ, Jaspar JM, Damas P, et al. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis 2002;61:161–6.
- Ertenli I, Kiraz S, Calguneri M, Celik I, Erman M, Haznedaroglu IC, et al. Synovial fluid cytokine levels in Behget's disease. Clin Exp Ftheumatol 2001;19(5 Suppl 24):537–41.
- Shovman 0, Gilburd B, Zandman-Goddard G, Sherer Y, Orbach H, Gerli R, et al. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis. Clin Dev Immunol 2005;12: 197–202.
- van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004;50:709–15.